Abstract 019: Changes in Gut Microbial Metabolites and Risk of Coronary Heart Disease in US Women: the Nurses’ Health Study — Yoriko Heianza (2019) | RDL Network
Abstract 019: Changes in Gut Microbial Metabolites and Risk of Coronary Heart Disease in US Women: the Nurses’ Health Study
Article 2019 en
Authors
YH
Yoriko Heianza
WM
Wenjie Ma
JD
Joseph A. DiDonato
Abstract
2 min read
Introduction: Circulating levels of gut microbial metabolites, trimethylamine N-oxide (TMAO) and its nutrient precursors of choline and L-carnitine, have been suggested as risk factors for coronary heart disease (CHD). Whether changes in gut microbial metabolites are associated with the CHD incidence remains unknown. Hypothesis: We assessed the hypothesis that long-term (over 10 years) changes in plasma levels of TMAO, choline, and L-carnitine would be associated with the risk of CHD. Methods: This prospective nested case-control study included a total of 768 women (385 incident cases of fatal CHD and nonfatal myocardial infarction and 383 controls) who had data on blood concentrations of TMAO, choline, and L-carnitine at 2 time points, 10 years apart (1989-90, and 2000-01). We identified incident cases of CHD from the date of the second blood collection through 2014. Results: Higher TMAO levels at the second collection were associated with higher risk of CHD (relative risk (RR) 1.22 [95% CI: 1.05, 1.42] per 1 SD increment in log-transformed TMAO) in multivariate analyses controlling for traditional risk factors. Compared with women with low TMAO levels (lower two tertiles) at both time points, the RR was 1.74 (95% CI: 1.05, 2.89) for those with elevated levels of TMAO (the highest tertile) at both time points. Regardless of metabolite levels at the first collection, increases in TMAO or L-carnitine from the first to second collections were significantly associated with an increased risk of CHD (Fig. panels A-B). Women who had increases in both TMAO and L-carnitine had a particularly elevated risk of CHD (RR 2.12, 95% CI: 1.25, 3.59), as compared to those with decreases in both metabolites. Adherence to healthy dietary habits attenuated the associations of TMAO with CHD risk (Fig. panel C). Conclusions: Long-term increases in TMAO were significantly predictive of subsequent risk for CHD among women. The associations may be modified by the nutrient metabolite precursor, L-carnitine, and adherence to healthy dietary habits.
Marta Guasch‐Ferré, Frank B Hu, Miguel Ruiz‐Canela, Mònica Bulló, Edward Yu, Yan Zheng, Estefanía Toledo, Dong D. Wang, Adela Hruby, Dolores Corella, Enrique Gómez‐Gracia, Miquel Fiol, Ramón Estruch, José Lapetra, Montserrat Fitó, Fernando Arós, Lluís Serra‐Majem, Emilio Ros, Liming Liang, Clary B. Clish, Miguel Ángel Martínez‐González, Jordi Salas‐Salvadó
Christopher Papandreou, Mònica Bulló, Pablo Hernández‐Alonso, Miguel Ruiz‐Canela, Jun Li, Marta Guasch‐Ferré, Estefanía Toledo, Clary B. Clish, Dolores Corella, Ramón Estruch, Emilio Ros, Montserrat Fitó, Ángel M. Alonso‐Gómez, Miquel Fiol, José Manuel Santos‐Lozano, Lluís Serra‐Majem, Liming Liang, Miguel Ángel Martínez‐González, Frank B Hu, Jordi Salas‐Salvadó
Discussion(0)
No comments yet. Be the first to comment.